Drawing for HYDRA BIOSCIENCES

USPTO serial 76439310

HYDRA BIOSCIENCES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RIRIE, VERNA BETH
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HYDRA BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Bevilacqua

MICHAEL J BEVILACQUA HALE AND DORR LLP60 STATE ST STE 25BOSTON, MA 02109-1816UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals preparations for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules; pharmaceutical preparations in the nature of biologicals for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of interference with or effects upon one or more signaling molecules; and pharmaceuticals in the nature of genetic therapies for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules; oral contraceptives; spermicides; tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or differentiating cells, and cellular contractile organizational structures for identifying molecules that can induce desirable cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic and vision diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 14, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 12, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 13, 2004FAXXFAX RECEIVED—
Aug 30, 2004CFITCASE FILE IN TICRS—
Aug 24, 2004FAXXFAX RECEIVED—
Aug 17, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 9, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 4, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2003NPUBNOTICE OF PUBLICATION—
Aug 14, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2003MAILPAPER RECEIVED—
Dec 16, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2002DOCKASSIGNED TO EXAMINER—
Nov 19, 2002DOCKASSIGNED TO EXAMINER—
Nov 4, 2002DOCKASSIGNED TO EXAMINER—
Oct 31, 2002DOCKASSIGNED TO EXAMINER—
Aug 28, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 28, 2002MAILPAPER RECEIVED—

Frequently asked questions

Related guidance